Loading...
Symbols:
Loading...
Symbols:
Amylin Pharmaceuticals Inc. (AMLN)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Amylin Pharmaceuticals Inc. (AMLN)
84 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on AMLN
- Mike Huckman(15)
- SA Editor Miriam Metzinger(11)
- SA Editors(10)
- SA Editor Eli Hoffmann(4)
- BioBlogger (4)
Most popular authors
(tracked in watchlists)
- Bespoke Investment Group(529)
- Trader Mark(453)
- SA Editor Eli Hoffmann(379)
- Andrew Wilkinson(300)
- SA Editor Rachael Granby(162)
Most commented on authors
- SA Editor Eli Hoffmann(28)
- SA Editor Rachael Granby(21)
- Trader Mark(14)
- SA Editor Miriam Metzinger(12)
- Mike Huckman(11)
- Will Carl Icahn Come to Amylin's Rescue?
- How Pharma Is Faring in the Financial Crisis
- Amylin Facing Crisis of Confidence
- Post Election Stock and Sector Performance
- Wall Street Breakfast: Must-Know News
- Tuesday Options Update: ADM, KGC, AMLN, ALKS, SOLF, HLF & EXPD
- Wall Street Breakfast: Must-Know News
- Thursday Options Outlook: LEH, MER, GE, PTIE, AMLN, UNH, DBA
- Eli Lilly's Brewing Battle With Bristol-Myers
- Five Presentations from the Recent Biotech Investment Conference
- Five Biopharma Companies Drop on Negative Drug News
- Wednesday Options Update: LEH, AMLN, XLE, NTAP, CLNE, HOS, DLTR, TEL, ESI
- Amylin, Lilly: Another Case of a Panic Driven Sell-Off
- Wall Street Breakfast: Must-Know News
- Drug Safety Updates For Elan, Biogen, Amylin, and Lilly
- Should You Oogle Google - Fast Money Recap (8/26/08)
- Amylin Shares Gain Ground on Outlook for Byetta
- Latin Lovers - Fast Money Recap (8/21/08)
- Why I'm Buying Amylin Now
- Wednesday Options Update: MER, BAC, FNM, AMGN, AMLN, LLY, MEA, GE
- AstraZeneca Gives FluMist Spray a Shot in the Arm
- 5 Potential Buyout Targets in Biotech - Barron's
- My Model Biotech Picks: What's Hot and What's Not
- So Much for the Summer Doldrums with Drugmakers
- Icahn Racks Up Gains in ImClone, Motorola, and Amylin
- Wall Street Breakfast: Must-Know News
- Roche's Genentech Offer Sends Ripples Through Biotech
- Pfizer, Merck and Lilly Partner to Get "Enlightened"
- Amylin Has Yet to Crack Tough Diabetes Market
- In GLP-1 Wars, Novo & Others Knock at Amylin’s Door; Find Amylin Moved to Pricier Digs
- Is Lilly and Amylin's Byetta Better?
- Lehman's a Lemon - Fast Money Recap (6/9/08)
- Analyst Notes: Lilly Gets A Lift, Pfizer Goes Pfft
- Dell Rescues Tech - Fast Money Recap (5/30/08)
- Oil: Speculation vs. Supply and Demand - Fast Money Recap (5/29/08)
- Icahn Boosts Stake in Amylin to 6.5%, Seeks Additional Talks
- Oncology Conference Countdown: What Will Pharma and Biotech Companies Report?
- Two Down Days to Start the Week
- Halfway Through Earnings Season, No Home Runs for Big Pharma
- Pfizer Fizzles, Fast Money Recap (4/18/08)
- Pfizer Fizzles, Fast Money Recap (4/18/08)
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »